Czechia, March 13 -- Czechia based Movianto Ceska republika s.r.o. has secured contract from Vojenska nemocnice Olomouc for Pharmaceutical products LEBRIKIZUMAB II 2025. The value of the contract is worth 380950080 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....